Jaffetilchin Investment Partners, LLC Intra Cellular Therapies, Inc. Transaction History

Jaffetilchin Investment Partners, LLC

$1.3 Billion
Q3 2024

A detailed history of Jaffetilchin Investment Partners, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 5,196 shares of ITCI stock, worth $433,450. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,196

Previous 5,196 -0.0%

Holding current value

$433,450

Previous $355,000 6.76%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$64.76 - $79.84 $16,190 - $19,960	-250 Reduced 4.59%	5,196 $355,000
Q1 2024 May 16, 2024	SELL	$64.37 - $75.65 $6,437 - $7,565	-100 Reduced 1.8%	5,446 $376,000
Q4 2023 Feb 13, 2024	SELL	$46.37 - $73.65 $37,096 - $58,920	-800 Reduced 12.61%	5,546 $397,000
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $9,636 - $11,858	-185 Reduced 2.83%	6,346 $330,000
Q2 2023 Aug 15, 2023	SELL	$54.67 - $66.44 $10,387 - $12,623	-190 Reduced 2.83%	6,531 $413,000
Q1 2023 May 11, 2023	BUY	$43.8 - $56.99 $8,102 - $10,543	185 Added 2.83%	6,721 $363,000
Q4 2022 Feb 10, 2023	SELL	$44.07 - $54.45 $1.04 Million - $1.29 Million	-23,700 Reduced 78.38%	6,536 $345,000
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $19,940 - $28,015	-467 Reduced 1.52%	30,236 $1.41 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $27,434 - $41,878	-638 Reduced 2.04%	30,703 $1.75 Million
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $33,471 - $53,645	-864 Reduced 2.68%	31,341 $1.73 Million
Q4 2021 Feb 17, 2022	SELL	$35.2 - $53.42 $407,440 - $618,336	-11,575 Reduced 26.44%	32,205 $1.69 Million
Q3 2021 Oct 25, 2021	SELL	$28.72 - $42.49 $1.35 Million - $2 Million	-47,158 Reduced 51.86%	43,780 $1.63 Million
Q2 2021 Aug 09, 2021	BUY	$29.3 - $44.5 $1.38 Million - $2.1 Million	47,197 Added 107.9%	90,938 $3.32 Million
Q1 2021 May 10, 2021	SELL	$30.8 - $39.51 $5,790 - $7,427	-188 Reduced 0.43%	43,741 $1.48 Million
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $1.03 Million - $1.42 Million	43,929 New	43,929 $1.4 Million

Others Institutions Holding ITCI

# of Institutions

379

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.

Account

Jaffetilchin Investment Partners, LLC Intra Cellular Therapies, Inc. Transaction History